ALSUntangled # 69: astaxanthin.

Area of Science:

• Neurodegenerative diseases
• Pharmacology
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited treatment options.
• Alternative and off-label treatments are being explored to manage ALS progression.
• Astaxanthin, a natural antioxidant, possesses anti-inflammatory and anti-apoptotic properties that may benefit neuroprotection.

Approach:

• This review examines astaxanthin, a natural compound, for its potential therapeutic effects in ALS.
• Plausible mechanisms include antioxidant, anti-inflammatory, and anti-apoptotic properties.

Key Points:

• No specific pre-clinical studies for ALS exist, but one case reported "ALS reversal" with a combination therapy including astaxanthin.
• Astaxanthin has demonstrated antioxidant, anti-inflammatory, and anti-apoptotic effects, which are relevant to ALS pathology.
• Current evidence is limited, with no clinical trials conducted specifically on astaxanthin in PALS.

Conclusions:

• Astaxanthin demonstrates plausible mechanisms for potentially slowing ALS progression.
• There is a lack of clinical trials investigating astaxanthin in people with ALS.
• Further pre-clinical and clinical research is warranted to determine astaxanthin's efficacy and safety in ALS models and patients.